[Are PPAR-gamma-agonists a secure choice in treatment of overweight diabetic patients?].
Larsen
P J
PJ
D002839:Chromans / Q000009:adverse effects / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009765:Obesity; D013844:Thiazoles / Q000009:adverse effects / Q000627:therapeutic use*; D015430:Weight Gain / Q000187:drug effects
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles